Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03047395 |
|---|---|
| Brief Title: | A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) (LIMMITLESS) |
| First Submitted : | February 7, 2017 |
| First Submitted that Met QC Criteria : | February 7, 2017 |
| First Posted : | February 9, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 9, 2022 |
| Last Update Posted : | September 14, 2022 |